← All Trinity Biotech PLC filings

Trinity Biotech PLC F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
TRIB
Trinity Biotech PLC
F-1/A: Trinity Biotech Terminates Equity Purchase Agreement
Trinity Biotech plc has terminated its Standby Equity Purchase Agreement with YA II PN, LTD., removing unsold shares from its registration statement.
NASDAQ
TRIB
Trinity Biotech PLC
F-1/A: Trinity Biotech PLC: Secondary Offering Update
Trinity Biotech PLC files a post-effective amendment to its F-1 registration statement to update information regarding a secondary offering of up to 33,752,429 ADSs.
NASDAQ
TRIB
Trinity Biotech PLC
F-1: Trinity Biotech Secures $25M Equity Line, Faces Nasdaq Delisting Threat
Trinity Biotech PLC has entered a $25 million equity purchase agreement while simultaneously addressing Nasdaq non-compliance issues and significant debt obligations.
NASDAQ
TRIB
Trinity Biotech PLC
F-1: Trinity Biotech Registers $39M Secondary Offering
Trinity Biotech PLC files to register up to 55.9 million ADSs for resale by Perceptive Credit Holdings, converting existing debt into equity.